GENE ONLINE|News &
Regenx Completes $230,833 Private Placement Financing with Units Priced at $0.15 Each
Regenx has announced the completion of a non-brokered private placement financing, securing gross proceeds of $230,833. The company disclosed the details in a statement released on April 1, 2026. This financing initiative involved the issuance of units priced at $0.15 each.
Each unit issued in the offering consists of one common share and one-half of a common share purchase warrant. According to Regenx, each whole warrant entitles the holder to acquire an additional common share at an exercise price of $0.25 for a period of two years from the closing date. The company stated that it intends to use the funds raised through this financing for general working capital purposes and ongoing corporate initiatives.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: April 1, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
LATEST
IonQ and University of Maryland Expand QLab Partnership to Advance Quantum Networking Technologies
2026-04-13
Sharon AI Completes Early Receipt of Remaining Payment from Texas Data Centers Joint Venture Sale
2026-04-13
B2Gold Corp. to Release Q1 2026 Financial Results and Host Conference Call for Stakeholders
2026-04-13
Everyday People Financial Corp. Receives Conditional TSX Venture Exchange Approval to Divest Financial Services Division
2026-04-13
Coinbase to Release Q1 2026 Financial Results on May 7 with Webcast Scheduled for 2:30 PM PT
2026-04-13
EVENT
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
